It has been a busy week for product launches from Tekcapital PLC’s (LON:TEK) medtech unit Belluscura, and there was another announced today.
- Read TekCapital's medtech unit launches products either side of the pond
- Read Tekcapital backing next generation portable oxygen concentrator
The company has launched in the USA a device called Passport.
It is a disposable trocar – a type of sharp pointed instrument, used to withdraw fluid from a cavity.
The instrument is typically used in 'keyhole' surgery.
Passport features the patented SmartTip technology, which is designed to be compatible with the industry-standard robotic surgical systems.
“Passport, with its unique seal, is used as the access point for the endoscope camera, which allows the surgeon to visualise the procedure site. The SmartTip controls the cutting blade to prevent accidental deployment inside the patient and potential tissue damage.” Tekcapital’s statement disclosed.
"The launch of this Passport trocar provides Belluscura with a presence in the surgical device field. Passport is the first of a family of trocars and cannulae that Belluscura will seek to launch over the coming years. Together, these will form a range of products to support surgeons in an array of specialties,” said Bob Raulker, Belluscura’s chief executive officer.